CD8A and neoplasm: Interestingly, as the recurrent bacterial peptides in tumors being identified,106 tumor‐specific CD8+ T cells with a second T‐cell receptor (TCR) that recognizes a bacterial antigen were generated, and treatment of solid tumors with the dual‐specific T cells and intratumor injection of bacteria showed therapeutic potentials.174